Sven Klussmann
Chief Tech/Sci/R&D Officer at NOXXON Pharma AG
Profile
Sven Klussmann was the founder of TME Pharma NV, which was founded in 1997, where he held the title of Chief Scientific Officer.
Currently, he is the Chief Scientific Officer at NOXXON Pharma AG since 1997.
Dr. Klussmann's education includes an undergraduate degree from Freie Universität Berlin.
Sven Klussmann active positions
| Companies | Position | Start |
|---|---|---|
NOXXON Pharma AG
 NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Chief Tech/Sci/R&D Officer | 1996-12-31 |
Former positions of Sven Klussmann
| Companies | Position | End |
|---|---|---|
| TME PHARMA N.V. | Founder | - |
Training of Sven Klussmann
| Freie Universität Berlin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TME PHARMA N.V. | Health Technology |
| Private companies | 1 |
|---|---|
NOXXON Pharma AG
NOXXON Pharma AG BiotechnologyHealth Technology NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany. | Health Technology |
- Stock Market
- Insiders
- Sven Klussmann
